Bernard H. Davis
About
In The Last Decade
Bernard H. Davis
39 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 712
- Hepatology 595
- Epidemiology 443
- Surgery 233
- Pathology and Forensic Medicine 233
Countries citing papers authored by Bernard H. Davis
This map shows the geographic impact of Bernard H. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard H. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard H. Davis more than expected).
Fields of papers citing papers by Bernard H. Davis
This network shows the impact of papers produced by Bernard H. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard H. Davis. The network helps show where Bernard H. Davis may publish in the future.
Co-authorship network of co-authors of Bernard H. Davis
This figure shows the co-authorship network connecting the top 25 collaborators of Bernard H. Davis. A scholar is included among the top collaborators of Bernard H. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard H. Davis. Bernard H. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 77 | |
| 3 | 67 | |
| 4 | 97 | |
| 5 | 25 | |
| 6 | Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. | 67 |
| 7 | 4 | |
| 8 | 84 | |
| 9 | 87 | |
| 10 | 4 | |
| 11 | 14 | |
| 12 | 30 | |
| 13 | 37 | |
| 14 | 24 | |
| 15 | 6 | |
| 16 | 126 | |
| 17 | 15 | |
| 18 | 76 | |
| 19 | 113 | |
| 20 | Type I and type III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CCl4 rat model. | 27 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.